Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    Prof. Pierre Guertin

    Prof. Pierre Guertin
    Laval University, Canada
    Email: pierre.guertin@crchudequebec.ulaval.ca
    Tel: +1 418-525-4444, pos
    Fax: +1 418-654-2753

    More Info.

    Editorial Board

    Fatima Morales Marin
    Medicinal Chemistry, Genetics, Cancer Research
    Temple University
    USA
    fatimamorales@ugr.es
    IJPSDR

    Research Interest: Cancer, CDK inhibitors, Purine Derivatives, Nutrition, Parasitism, Phytotherapy, Molecular Biology, Genetics, Cancer Research, Medicinal Chemistry.

    More Info.
    BEATA SARECKA-HUJAR
    phd
    Department of Pharmaceutical Technology
    Medical University of Silesia in Katowice
    Poland
    beatasarecka@poczta.onet.pl
    IJPSDR

    After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.


    Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

    Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.


    List of Publications:
    Selected articles of my authorship:
    1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

    2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

    3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

    4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

    5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

    6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

    7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

    8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

    9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

    10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

    11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

    12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

    13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

    14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

    15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

    16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

    17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

    18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

    19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

    20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

    21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

    22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.


    More Info.
    Ruofeng Shang
    Lanzhou Institute of Husbandry and Pharmaceutical Sciences
    China
    shangrf1974@163
    IJPSDR

    Research Interest: Medicinal Chemistry, Medicinal and Pharmaceutical Chemistry.


    More Info.
    Priyanka S. Bhatt
    Department of Pharmaceutical Science
    University of South Florida
    USA
    psbhatt@health.usf.edu
    IJPSDR
    More Info.
    Nian-Qiu Shi
    Department of Pharmaceutics School of Pharmacy Ji Lin Medical College
    China
    shinianqiu2009@163.com
    IJPSDR

    Research Interest: Targeting drug delivery systems (TDDS), Multifunctional nanocarriers or macromolecules have many advantages for diseases treatments. Our lab employs diverse targeting delivery systems including conjugate, liposomes and micelles to deliver anticancer drug or gene for tumor therapy. In this process, we unitize stimuli-responsive strategies (e.g. enzyme-responsive) to obtain the targeting therapy of tumor. Cell-penetrating peptides (CPPs) are also adopted to cross cellular barriers. Internalization mechinisms of CPPs or CPP-cargoes are also focused by us.

    More Info.
    Thierry Vandamme
    Professor
    University of Strasbourg
    Belgium
    vandamme@unistra.fr
    IJPSDR

    Research Interest: Medicine, Pharmacology, Pharmacy, Cell Culture,Genetic Engineering, Medicinal and Pharmaceutical Chemistry, Medical Neurosciences, Pharmaceutical Development.

    More Info.
    Xiaodong Zheng
    Department of Pathophysiology
    Harbin Medical University
    China
    xzheng2001@163.com
    IJPSDR

    Research Interest: Ophthalmology, Cataract Surger,Cornea, Refractive Eye Surgery, Keratoconus.


    More Info.
    Dr. Hitesh Chavda
    Research Scientist
    Formulation and Development, Gowrie Research Pvt Ltd
    HNGU, Patan
    India
    hitesh.chavda@bnsthamelabs.co.uk
    IJPSDR

    Dr. Chavda is dedicated and highly motivated research scientist with more than 13 years of rich Industry-Academic experience. His area of interest is development of formulations including Oral solids, Liquids, Semi-solids, Parenterals and NDDS. He has developed stable and robust formulations across various dosage forms. He has sound understanding of formulation and development using QbD and DOE approaches. He has understanding of product development lifecycle, clinical and regulatory requirements of regulatory bodies like UKMHRA, USFDA etc. There are more than 35 International and National research publications to his credit. In addition to that he has several magazines related articles and Books publications. He is providing editorial service for international journals. He is serving as reviewer at Elsevier, Bentham Sciences, Informa Healthcare, and Wiley Journals.

    List of publications:

    1. Chavda HV*, Neerumalla S, Patel A, Poptani S. Excipients: The Real Players behind Robust

    Formulation. Indian Journal of Pharmaceutical Education and Research. January 2019; 53(1):

    5-7.

    2. Chavda HV*. Artificial Neural Networks in Pharma Product Development. Chronicle

    Pharmabiz. May 2018; 18(23): 42-43.

    3. Chavda HV*. 3D printing: Upcoming revolution for pharmaceutical industry. Chronicle

    Pharmabiz. April 2018; 18(21): 10.

    4. Chavda HV*. Qbd in Developing Topical Dosage Forms. Elyns Journal of Pharmaceutical

    Research December 2016; 2(1): 90000106. [Short Communication]

    5. Chavda HV*. Nanopharmaceuticals: The Pharmaceuticals of Present Era. Elyns Journal of

    Pharmaceutical Research 2016; 1(2): 106e. [Editorial Article]

    6. Chavda HV*, Naik S, Mukhopadhyay P. QbD Concept Implementation for Excipients.

    Ingredients South Asia Magazine. Saffron Media Publication, November, 2016; 11: 119-120.

    7. Chavda HV*. Reforms in Pharmaceutical Education in India. Ingredients South Asia

    Magazine. Saffron Media Publication, April 16-30, 2016; 9(14): 48-51.

    8. Chavda HV*. African Market: Big Window of Opportunity. Ingredients South Asia Magazine.

    Saffron Media Publication, January 16-31, 2016; 9(8): 30-32.

    9. Chavda HV*. SPHs as an Unusual Upcoming Excipient. Ingredients South Asia Magazine.

    Saffron Media Publication, December 1-15, 2015; 9(5): 104-111.

    10. Chavda HV*, Patel RI, Patel CN. Preparation and Characterization of Ternary Solid Dispersion

    of Flunarizine Dihydrochloride. World Journal of Pharmaceutical Research (ISSN: 2277-7105)

    2015; 4(5): 2506-2521.

    11. Chavda HV*, Chavada G, Patel J, Rangpadiya K, Patel CN. Topical Vaginal Drug Delivery

    System Based on Superporous Hydrogel Hybrids. Protein & Peptide Letters (ISSN: 0929-8665,

    Impact Factor 1.735) 2014; 21(11): 1176-1184.

    12. Chavda HV*, Patel RD, Modhia IP, Patel CN. Role of Superporous Hydrogel Particles as a

    Superdisintegrant in Fast Disintegrating Tablet of Glipizide. Chronicles of Young Scientists

    (ISSN: 2229-5186) 2014; 5(1):11-19.

    13. Chavda HV*, Patel J, Chavada G, Dave S, Patel A, Patel CN. Self Nanoemulsifying Powder of

    Isotretinoin: Preparation and Characterization. Journal of Powder Technology. (ISSN: 2090-

    7737) 2013; 2013 Article ID 108569, 9 pages. [Cited on 15/11/2013].

    14. Chavda HV*, Modhia IP, Mehta A, Patel RD, Patel CN. Development of Bioadhesive Chitosan

    Superporous Hydrogel Composite Particles based Intestinal Drug Delivery System. BioMed

    Research International (ISSN: 2314-6133, Impact Factor 2.880) 2013; 2013 Article ID 563651,

    10 pages. [Cited on 06/08/2013]

    Page 7 of 12 Dr. Hitesh Chavda

    15. Chavda HV*, Patel SK, Patel CN. Insignificant Effect of Superporous Hydrogel Particles as a

    Superdisintegrants in Fast Dispersible Tablets of Aceclofenac. Online article PharmaTutor

    (ISSN: 2347 - 7881) 2013 (Published on Web 31/01/2013). Available from:

    http://www.pharmatutor.org/articles/ insignificant-effect-of-superporous-hydrogelparticles-

    as-superdisintegrants-in-fast-dispersible-tablets-of-aceclofenac?page=0,0 [Cited on

    31/01/2013].

    16. Chavda HV*, Patel RD, Modhia IP, Patel CN. Preparation and Characterization of

    Superporous Hydrogel Based on Different Polymers. Int J Pharm Investig (ISSN: 2230-973X)

    2012; 2(3):134-139.

    17. Chavda HV*, Patel MS, Patel CN. Preparation and In Vitro Evaluation of Guar Gum Based

    Triple-Layer Matrix Tablet of Diclofenac Sodium. Res Pharm Sci (ISSN: 1735-5362, Impact

    Factor 0.220) 2012; 7(1): 57-64.

    18. Chavda HV*, Patel CN. Pharmaceutical Formulations for Oral Transmucosal Drug Delivery.

    News Tech 2011; 29:10-11.

    19. Chavda HV*, Patel CN, Modh KM, Panigrahi B. Preparation, Characterization and In Vitro

    Evaluation of Carbopol-based Superporous Hydrogel Composite. Indian J Pharm Sci (ISSN:

    0250-474X, Impact Factor: 0.626) 2011; [Accepted on 12/05/2011].

    20. Chavda HV*, Chaudhari TM, Patel CN. Antacids Incorporation in Immediate Release Tablets

    Failed to Improve the Stability of Omeprazole in Acidic Media. J Pharm Negative Results

    (ISSN: 0976-9234) 2011; 2(2):73-77.

    21. Chavda HV*, Patel CN. Preparation and in vitro evaluation of a stomach specific drug delivery

    system based on superporous hydrogel composite. Indian J Pharm Sci (ISSN: 0250-474X,

    Impact Factor: 0.626) 2011; 73(1):30-37.

    22. Chavda HV*, Patel CN. Effect of Crosslinker Concentration on Characteristics of Superporous

    Hydrogel. Int J Pharm Investig (ISSN: 2230-973X) 2011; 1(1):17-21.

    23. Chavda HV*, Patel CN. A Newer Formulation Approach: Superporous Hydrogel Composite-

    Based Bioadhesive Drug-Delivery System. Asian J Pharm Sci (ISSN: 1818-0876, Impact Factor

    0.250) 2010; 5(6): 239-250.

    24. Chavda HV*, Patel CN. Chitosan Superporous Hydrogel Composite-Based Floating Drug-

    Delivery System: A Newer Formulation Approach. J Pharm Bioall Sci (ISSN: 0976-4879,

    Impact Factor 0.175) 2010; 2(2): 124-131.

    25. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

    Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

    In Vitro Evaluation. Inventi Impact: NDDS (ISSN: 2229-4147) 2010; 2: Article ID: 2010nd70a

    (Published on Web 15/07/2010; www.inventi.in).

    26. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

    Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

    In Vitro Evaluation. Inventi Rapid: NDDS (e-ISSN: 0976-3791) 2010; 1(1): Article ID:

    2010nd70a (Published on Web 13/04/2010; www.inventi.in).

    27. Chavda HV*, Patel CN, Anand IS. Biopharmaceutics Classification System. Syst Rev Pharm

    (ISSN: 0975-8453) 2010; 1(1): 62-69.

    28. Chavda HV*, Patel CN. Preparation and Characterization of Swellable Polymer-based

    Superporous Hydrogel Composite of Poly (Acrylamide-co-Acrylic Acid). Trends Biomater Artif

    Organs (ISSN: 0971-1198, Impact Factor: 0.675) 2010; 24(2): 83-89.

    29. Chavda HV*, Patel CN. Effects of Solvent Treatments on Characteristics of Superporous

    Hydrogels. Ethiopian Pharm J (ISSN: 1029-5933) 2009; 27(1): 16-24.

    30. Chavda HV*, Patel CN, Karen HD. Preparation and Characterization of Chitosan-Based

    Superporous Hydrogel Composite. J Young Pharm (ISSN: 0975-1483) 2009; 1(3): 199-204.

    31. Chavda HV*, Patel CN. Aquaporins: Secret Highways for Water Transport. Pharm Reviews

    (ISSN: 1918-5561) 6(2), Apr 11, 2008.

    Page 8 of 12 Dr. Hitesh Chavda

    32. Chavda HV*, Patel CN, Patel AM, Patel BN. Supercritical Fluid: Green Solvent for Tomorrow.

    Pharm Reviews (ISSN: 1918-5561)5(3), May 16, 2007.

    33. Chavda HV*. Dendrimers: Polymers of 21st Century. Pharm Reviews (ISSN: 1918-5561) 5(1),

    Feb. 02, 2007.

    Co-author:

    34. Modi J*, Patel JK, Chavda HV. Superporous Hydrogel: A Supreme Approach for Gastric

    Retention. Online article PharmaTutor (ISSN: 2347 - 7881) 2012 (Published on Web

    03/08/2012). Available from: http://www.pharmatutor.org/articles/superporous-hydrogela-

    supreme-approach-for-gastric-retention [Cited on 31/01/2013].

    35. Karen HD*, Anand IS, Patel CN, Chavda HV, Patel JK. Formulation and Evaluation of

    Amphotericin-B as A Lyophilized Product. J Global Pharma Tech (ISSN: 0975-8542) 2010;

    2(2): 75-78.

    36. Parikh BN*, Gothi GD, Patel TD, Chavda HV, Patel CN. Microsponge as Novel Topical Drug

    Delivery System. J Global Pharma Tech (ISSN: 0975-8542) 2010; 2(1): 17-29.

    More Info.
    Daniela Benedec
    Department of Pharmacognosy
    Iuliu Hatieganu University of Medicine and Pharmacy
    Romania
    dani_67ro@yahoo.com
    IJPSDR

    Research Interest: Natural Product Chemistry,Nanotechnology, Essential Oils, Nanobiotechnology, Antioxidants,Veterinary Medicine, Dermatology, Pharmacy, Medicinal and Pharmaceutical Chemistry, Thin Films and Nanotechnology, Medicinal Plants and Herbs, Plant Biotechnology, Antioxidant Activit, Polyphenols, Phenolic Compoun, DPP, Botan, Microbiology, Environmental Chemistry, Antioxidant Assays, Flavonoids, Biotechnology, Bioactivi, Phytochemicals,LC-MS, Medicinal Plants, Spectroscopy, Chromatography, Natural Products, Ethnomedicine, Natural Product Isolatio.

    More Info.
    Qiusheng Zheng
    Binzhou Medical University
    China
    zqsyt@sohu.com
    IJPSDR

    Research Interest: Reactive Oxygen Species, Apoptosis, Signaling Pathways, Western Blot, Phosphorylation, Superoxide Dismutase, NADPH Oxidase, Monocytes

    More Info.
    Amanj Baker
    Researcher
    Medicines and Health
    University of Nottingham
    UK
    paxaib@nottingham.ac
    IJPSDR

    Research Interest: Drug utilisation, Public Health, Cardiology, Diabetology.

    More Info.
    Jing Tang
    Associate Professor
    Shanghai Jiao Tong University
    China
    angel_tj99@126.com
    IJPSDR

    Research Interest: Antibiotics, Virus, Infected Diseases, Drug–Drug Interactions.


    More Info.
    Wei Wang
    Professor
    School of Pharmacy
    Hunan University of Chinese Medicine
    China
    wangwei402@hotmail.com
    IJPSDR

    Research Interest: Isolation and structure elucidation of natural products, Search for bioactive compounds, Antifungal, Anticancer and anti-inflammatory phytochemicals from traditional Chinese medicine (TCM) or other ethnic medicine (e.g. Tujia, Miao and so on);Chemical and pharmacological study of Chinese medicine; Quality control study of Chinese medicine.

    More Info.
    Yike Zou
    Department of Chemistry
    University of Pennsylvania
    USA
    zouyike@sas.upenn.edu
    IJPSDR

    Research Interest: Organic Chemistry: Total Synthesis of Complex Natural Product, Computational Chemistry: Conformational Analysis, Molecular Modelling and Spectra Simulation. Natural Product Discovery: Isolation, Structural Elucidation, and Absolute Configuration Deter-mination of Natural Product.

    More Info.
    Hong-Tao Xiao
    Professor
    Department of Pharmacy Sichuan Provincial Peoples Hospital
    China
    xht927@163.com
    IJPSDR

    Research Interest: Experimental and clinical pharmacology about natural product, Pharmacokinetics of  medicinal plant.


    More Info.
    View more
    mendeley

    An overview on NMR spectroscopy based metabolomics

    DOI Logo 10.17352/ijpsdr.000029

    Published On: June 03, 2020 | Pages: 016 - 020

    Author(s): Nalini Kanta Sahoo*, G Tejaswini, Madhusmita Sahu and KS Muralikrishna
    Abstract View Full Article View
    mendeley

    Bacteriocin-like protein produced Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria

    DOI Logo 10.17352/ijpsdr.000028

    Published On: June 03, 2020 | Pages: 012 - 015

    Author(s): Monthon Lertcanawanichakul* and Kittisak Chawawisit
    Abstract View Full Article View
    mendeley

    Pharmaceutical Nanotechnology: A Therapeutic Revolution

    DOI Logo 10.17352/ijpsdr.000027

    Published On: May 05, 2020 | Pages: 009 - 011

    Author(s): Douglas Dourado*
    Abstract View Full Article View
    mendeley

    Regarding the measurement of therapeutic adherence

    DOI Logo 10.17352/ijpsdr.000026

    Published On: April 17, 2020 | Pages: 008 - 008

    Author(s): Sara Malo*
    Abstract View Full Article View
    mendeley

    Jaiphal Myristica fragrans (Houtt)-A promising seed for pharmaceutical industries

    DOI Logo 10.17352/ijpsdr.000025

    Published On: March 21, 2020 | Pages: 006 - 007

    Author(s): Ankita Chakravarty, Jai Gopal Sharma*
    Abstract View Full Article View
    mendeley

    Validation of spectrophotometric method for determination of esomeprazole and ciprofloxacin in their pure and dosage forms

    DOI Logo 10.17352/ijpsdr.000024

    Published On: January 29, 2020 | Pages: 001 - 005

    Author(s): Mohsen M Zareh, Monir Z Saad, Wafaa S Hassan, Mostafa E Elhennawy and Mahmoud M Sebaiy*
    Abstract View Full Article View
    mendeley

    Visible light and UV-assisted photodegradation of phenylephrine by bulk NiO and NiO immobilized on magnetic polypyrrole support

    DOI Logo 10.17352/ijpsdr.000023

    Published On: December 31, 2019 | Pages: 016 - 024

    Author(s): Hossein Faghihian and Firoozeh Torki
    Abstract View Full Article View
    mendeley

    Plants and therapeutics: Interaction

    DOI Logo 10.17352/ijpsdr.000022

    Published On: December 31, 2019 | Pages: 013 - 015

    Author(s): Shah Murad*, Hafiz Moeen-Ud-Din, Farid-Ud-Din, Abdul Ghaffar, Seema Shah Murad, Jamila Shah and Manal Rauf Mahar
    Abstract View Full Article View
    mendeley

    In vitro conservation of mangrove for pharmaceutical interest

    DOI Logo 10.17352/ijpsdr.000021

    Published On: July 24, 2019 | Pages: 009 - 012

    Author(s): Chinnappan Ravinder Singh*
    Abstract View Full Article View
    mendeley

    Preparation of itraconazole nanoparticles and its topical nanogel: Physicochemical properties and stability studies

    DOI Logo 10.17352/ijpsdr.000020

    Published On: January 03, 2019 | Pages: 001 - 008

    Author(s): Kamlesh Amrut Wadile, Pradum Pundlikrao Ige* and Raju Onkar Sonawane
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR